Faculty Profiles

Colleges and Departments

Dr. Liqin Du

  • Associate Professor - Chemistry and Biochemistry

Biography and education

2009: Postdoctoral Fellow, McDermott Center for Human Growth and Development, UT Southwestern Medical Center at Dallas, Dallas, TX.

2004: Nutritional Sciences, University of Kentucky, Lexington, KY.

1998: Master of Medicine, Shanghai Second Medical University, Shanghai, China.

1992: Bachelor of Medicine (MD equivalent), Shanghai Medical University, Shanghai, China.

Teaching Interests

Research Interests

  • Du, Liqin (Principal). Molecular and therapeutic mechanisms of differentiation-inducing microRNA miR-506-3p in neuroblastoma, National Institute of Health, NCI, R15, Federal, $445639. (Submitted: June 6, 2019, Funded: September 1, 2020 - August 31, 2024). Grant.
  • Du, Liqin (Principal), Percent Contribution: %10, Kornienko, Alexander (Other), Percent Contribution: %5, Houhgton, Peter (Other), Percent Contribution: %1. Discovery of new differentiation agents for neuroblastoma therapy, National Institute of Health, NCI, R15, resubmissiom, Federal, $461574. (Funded: August 1, 2017 - July 31, 2020). Grant.
  • Du, Liqin (Principal). Targeting the human druggable genome for neuroblastoma differentiation therapy, Texas State University, REP Program, Texas State University, $8000. (Submitted: October 9, 2024, Funded: January 27, 2025 - May 31, 2026). Grant.
  • Du, Liqin (Principal). Developing new research directions in my laboratory, Texas State University, Presidential Research Award, Texas State University, $20000. (Submitted: September 15, 2023, Funded: July 2, 2024 - May 31, 2025). Grant.
  • Peterson, Ryan Loren, Lewis, Lysle, Du, Liqin, McLean, Robert J C. Fluorescence Microscope with Live-cell and high-resolution imaging capabilities, NIH, Federal, $194590.3. (Funded: July 1, 2024 - June 30, 2025). Grant.
View all grants
  • Zhao, G., Du, L., Zhang, L., & Jia, Y. (2021). LIM domain only 1: an oncogenic transcription cofactor contributing to the tumorigenesis of multiple cancer types. Chinese Medicine Journal, 134(9), 1017–1030. https://doi.org/10.1097/CM9.0000000000001487
  • Zhao, Z., Shelton, S. D., Oviedo, A., Baker, A. L., Bryant, C. P., Omidvarnia, S., & Du, L. (2020). The PLAGL2/MYCN/miR-506-3p interplay regulates neuroblastoma cell fate and associates with neuroblastoma progression. Journal of Experimental and Clinical Cancer Research, 39(1), 41. https://doi.org/10.1186/s13046-020-1531-2.
  • Saucedo, A., Muppidi, S., Smith, J. L., Jemal, M., Mesa-Diaz, N. L., Vernaza, A., … Kerwin, S. M. (2025). Caffeic acid phenethyl amide and analogues as anticancer agents against neuroblastoma. Book of Abstracts of the 269th ACS National Meeting & Exposition. Retrieved from https://www.fasebj.org/doi/abs/10.1096/fasebj.2019.33.1_supplement.634.5
  • Cardus, D. F., Smith, M. T., Vernaza, A., Smith, J. L., Del Buono, B., Parajuli, A., … Du, L. (2024). Systematic Analysis of miR-506-3p Target Genes Identified Key Mediators of Its Differentiation-Inducing Function. Genes, 15(10), 1–13. Retrieved from DOI: 10.3390/genes15101268
  • Saucedo, A., Subbarao, M., Jemal, M. J., Mesa-Diaz, N. L., Smith, J. L., Vernaza, A., … Kerwin, S. M. (2024). Flow and On-Water Synthesis and Cancer Cell Cytotoxicity of Caffeic Acid Phenethyl Amide (CAPA) Derivatives. Int J Mol Sci., 25(15), 1–11. https://doi.org/10.3390/genes15101268
View all scholarly/creative works
  • Award / Honor Recipient: 2024F Presidential Research Award for Faculty Development Leave, Texas State University. July 2, 2024 - May 31, 2025
  • Award / Honor Recipient: Hua Rui Prize, Sino-Swed Pharmaceutical Corp. Ltd. 1997
  • Award / Honor Recipient: Scholarship for Outstanding Graduate, Shanghai Second Medical University, China. 1996
  • Award / Honor Recipient: Scholarship for Outstanding Graduate, Shanghai Second Medical University, China. 1995
  • Award / Honor Recipient: First Prize of People’s Scholarship, Shanghai Medical University, China. 1991
View all awards
  1. Member

    Department Space Committee

  2. Member

    Department Personnel Committee

  3. Member

    COSE Undergraduate Scholarship Committee

  4. Editorial Review Board Member

    Technology in Cancer Research and Treatment (TCRT)

  5. Member

    Biochemistry Graduate Curriculum committee

  6. Member

    Biochemistry Curriculum committee

  7. View all activities